Research

An all-star lineup of experts in the fields of sports and neurology will share a stage on Jan. 27 to discuss concussions, a serious injury that has only recently been getting the attention it deserves.

Classified as: Athletics, brain injury, sport, Concussion, alain ptito, HEADS UP
Published on: 11 Jan 2017

The 85th Congrès annuel de l’Association francophone pour le savoir (Acfas) may be five months away, but McGill is already busy getting ready to host what is the largest French-language interdisciplinary conference in the world.

Read more

Classified as: ACFAS
Category:
Published on: 10 Jan 2017

Researchers urged not to miss Nov. 1 deadline for colloquia proposals.

Read more

Classified as: ACFAS
Category:
Published on: 10 Jan 2017

Have you ever met someone who just wasn’t into music? They may have a condition called specific musical anhedonia, which affects three-to-five per cent of the population.

Researchers at the University of Barcelona and the Montreal Neurological Institute and Hospital of McGill University have discovered that people with this condition showed reduced functional connectivity between cortical regions responsible for processing sound and subcortical regions related to reward.

Classified as: neuroscience, Robert Zatorre, specific musical anhedonia, fMRI, University of Barcelona
Published on: 4 Jan 2017

Drug shown to reduce new attacks/symptom progression in some patients

In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.

Classified as: Multiple Sclerosis, Amit Bar-Or, MS, Douglas Arnold, ocrelizumab
Published on: 22 Dec 2016

Study tracks patients to better understand effects and possible treatments

December 1 is World AIDS Day, a time to raise awareness about a disease that has afflicted 70 million people worldwide, 35 million of whom have died as a result.

Classified as: HIV, AIDS, Lesley Fellows, SIDA, Cognitive neuroscience, VIH, Journée mondiale du sida
Published on: 1 Dec 2016

Researchers have linked a debilitating neurological disease in children to mutations in a gene that regulates neuronal development through control of protein movement within neuronal cells.

Classified as: genetics, epilepsy, Peter McPherson, Epileptic encephalopathy, Chanshuai Han, DENND5A
Published on: 28 Nov 2016

Two researchers at the Montreal Neurological Institute and Hospital (MNI) of McGill University have received funding to study a devastating neurodegenerative disease that first appears in toddlers just as they are beginning to walk.

Classified as: genetics, stem cells, ARSACS, Charlevoix-Saguenay, University of Saskatchewan, ARSACS Foundation, Autosomal recessive spastic ataxia of Charlevoix-Saguenay, Neuro Giving
Published on: 24 Nov 2016

MNI scientists will study stem cells, genetic mutations to develop new treatments

Researchers at the Montreal Neurological Institute of McGill University who are playing key roles in uncovering the mechanisms underlying ALS will share in $3.9 million in research funding, part of $4.5 million announced on Nov. 23 by the ALS Society of Canada in partnership with Brain Canada.

Classified as: ALS, Brain Canada, C9ORF72, Canada Brain Research Fund, ALS Society of Canada
Published on: 23 Nov 2016

When two people smell the same thing, they can have remarkably different reactions, depending on their cultural background. Researchers at the Neuro have found that even when two cultures share the same language and many traditions, their reactions to the same smells can be different.

Classified as: neuroscience, Quebec, smell, france, olfactory system, cognitive
Published on: 21 Nov 2016

McGill University will receive more than $1.1 million for CBRAIN, one of the world’s most advanced computing platforms for brain research, through the Canada Foundation for Innovation’s (CFI) Cyberinfrastructure Initiative.

Read more

Category:
Published on: 2 Nov 2016

McGill University will launch an ambitious effort to advance understanding of the human brain and ease the burden of neurological and mental-health disorders, thanks to an $84 million, seven-year grant announced today under the federal government's Canada First Excellence Research Fund (CFREF).

Read more

Category:
Published on: 2 Nov 2016

Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer’s disease (LOAD), identifying its first physiological signs.

Read more

Category:
Published on: 2 Nov 2016

Scientists have identified a gene in the French-Canadian population that predisposes them to the development of intracranial aneurysm (IA), a potentially life threatening neurological condition that is responsible for approximately 500,000 deaths worldwide per year, half of which occur in people less than 50 years of age.

Using genetic analysis, the team of researchers found rare variations of one gene, RNF213, that appeared more frequently in IA patients than in the control group. Both patients and the control group came from French-Canadian families.

Classified as: Guy Rouleau, Simon Girard, intracranial aneurysm, moya moya disease, IA, RNF213
Published on: 31 Oct 2016

Pages